WASHINGTON, DC – Strides Pharma Inc. has issued a nationwide recall for nearly 90,000 bottles of children’s ibuprofen after consumers reported finding “foreign substances” inside the liquid medication. The U.S. Food and Drug Administration classified the move as a Class II recall on March 1 6. According to the agency, the recall was initiated following complaints of black particles and a gel-like mass found within the oral suspension. The affected product is Children’s Ibuprofen Oral Suspension, USP, 100 mg per 5mL, packaged in 4-ounce (120 mL) bottles. The medication was manufactured by Strides Pharma Inc. for Taro Pharmaceuticals USA Inc. Health officials say the recall impacts the following batches: Lot Numbers: 7261973A and 7261974A Expiration Date: Jan. 31, 2027 NDC Number: 51672-5321-8 A Class II designation indicates that exposure to the product may cause temporary or medically reversible health problems, though the risk of serious harm is considered remote. No serious adverse reactions have been reported to date in connection with the recall. Parents and caregivers are urged to check their medicine cabinets and stop using the affected lots immediately. Those whose children have experienced unusual symptoms after taking the medication should contact a healthcare provider. The FDA noted that this action is unrelated to a 2019 recall of ibuprofen products sold under brands such as Equate and CVS Health, which involved different manufacturers and concentration issues. For questions regarding the recall or to initiate a refund for the affected Children’s Ibuprofen Oral Suspension, you can contact Taro Pharmaceuticals USA Inc. through the following channels: Contact Information Customer Service Phone: 1-888-TARO-USA (1-888-827-6872) Alternative Phone: 914-345-9001 Email: [email protected] Website: Taro.com  king5.com +2 Business Hours Customer service is typically available Monday through Friday, 7:00 AM to 7:00 PM US Central Time.  FDA +1 Additional Resources If your child has experienced any adverse health issues related to this product, you should also report the incident to the FDA’s MedWatch Program at 1-800-332-1088.  ...read more read less